Latest filing published 17 Mar 2022 for Revance Therapeutics, Inc., €38k.
Insider track record
Abhay Joshi: trading record in brief
This profile gathers the share dealings of Abhay Joshi in Revance Therapeutics, Inc., where the filings describe the role as chief executive. We count 31 filings; the first trade dates from 14 December 2015 and the latest from 15 March 2022.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 17 March 2022 with a share grant (€38k) in Revance Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Abhay Joshi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,607 shares@ US$15.7959.7% of flowCommon StockSEC:0001209191-22-019727:0
- 2,902 shares@ US$13.353.0% of flowCommon StockSEC:0001479290-22-000023:1
- 2,151 shares@ US$13.3540.3% of flowCommon StockSEC:0001479290-22-000023:0
- 1,354 shares@ US$27.732.8% of flowCommon StockSEC:0001479290-21-000081:0
- 1,967 shares@ US$28.974.3% of flowCommon StockSEC:0001479290-21-000043:0
- 2,881 shares@ US$28.976.2% of flowCommon StockSEC:0001479290-21-000043:1
- 22,620 shares0Common StockSEC:0001479290-21-000037:0
- 7,382 shares@ US$25.1438.7% of flowCommon StockSEC:0001628280-20-014240:1
- 17,500 shares0Common StockSEC:0001628280-20-014240:0
- 1,354 shares@ US$15.504.2% of flowCommon StockSEC:0001209191-20-019835:0
- 3,325 shares@ US$25.3317.2% of flowCommon StockSEC:0001479290-20-000032:0
- 25,000 shares0Common StockSEC:0001479290-20-000015:0
- 4,441 shares@ US$22.8914.0% of flowCommon StockSEC:0001479290-20-000010:0
- 2,971 shares@ US$15.996.5% of flowCommon StockSEC:0001479290-19-000113:0
- 666 shares@ US$4.200.3% of flowCommon StockSEC:0001479290-19-000034:0
- 166 shares@ US$15.590.3% of flowCommon StockSEC:0001479290-19-000034:1
- 1,354 shares@ US$15.452.4% of flowCommon StockSEC:0001479290-19-000034:2
- 1,510 shares@ US$17.692.9% of flowCommon StockSEC:0001479290-19-000022:0
- 15,750 shares0Common StockSEC:0001479290-19-000014:0
- 4,466 shares@ US$20.199.7% of flowCommon StockSEC:0001479290-19-000008:0
- 4,260 shares@ US$19.919.2% of flowCommon StockSEC:0001479290-18-000123:0
- 666 shares@ US$2.550.1% of flowCommon StockSEC:0001479290-18-000060:0
- 1,509 shares@ US$31.754.0% of flowCommon StockSEC:0001479290-18-000027:0
- 11,750 shares0Common StockSEC:0001479290-18-000019:0
- 4,327 shares@ US$34.5012.8% of flowCommon StockSEC:0001479290-18-000011:0
25 of 31 declarations
